189 results
Page 5 of 10
8-K
EX-10.1
atyaau0jyq4ctyj8 hy
30 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-99.1
eljitx9gbblbhewgu9
26 Jul 19
AbbVie Reports Second-Quarter 2019 Financial Results
7:44am
8-K
EX-10.1
eh7m5xn
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
3j4i37jjmezn57nz6p1
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
car0d5ja xuylkbom
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-2.1
nc00p17zvs0jfb
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-99.1
g9m8x bp6h2fs4
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
8-K
EX-99
e50pt2709w
25 Apr 19
AbbVie Reports First-Quarter 2019 Financial Results
7:45am
PX14A6G
7p3fuof
1 Apr 19
Letter to shareholders
11:51am
PX14A6G
al9bz9o1tqyf8yidg
29 Mar 19
Letter to shareholders
11:12am
8-K
EX-99.1
pwjlm txpos
25 Jan 19
AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results
7:46am
8-K
EX-99.1
hehkza
17 Dec 18
AbbVie Announces Executive Leadership Changes
9:10am
8-K
EX-99.1
fax ewev1
2 Nov 18
AbbVie Reports Third-Quarter 2018 Financial Results
7:50am
424B5
xb0rvhuf7m
13 Sep 18
Prospectus supplement for primary offering
12:00am